Home | Recruitment

Pending

Trials by recruitment status

Public Title Date of registration Sponsorsort icon
Colilen IBS- Irritable Bowel Syndrome- adults-Phase III 28/11/2018 ABOCA
Anti SARS-CoV-2 gammaglobulin 30/06/2021 AICA
Biomodulina T in pediatric septic shock. Exploratory study 03/08/2020 BIOCEN
Efficacy of nasal provocation test with VALERGEN-DP, DS and BT 15/04/2019 BIOCEN
VALERGEN-combination of routes- Asthma-Adults-Phase II 14/02/2019 BIOCEN
Cicatrix Cream in cutaneous striae 2009-10-23 CATALYSIS
Cicatrix Cream in post surgical scarps and epidermic burn 2009-10-23 CATALYSIS
Efficacy of the Glicigen – Viusid in the treatment of external genitals anus wart in children 2010-09-04 CATALYSIS
Kardioli® nutritional supplement versus placebo in patients with chronic heart failure. Phase II. 03/03/2023 CATALYSIS
Obex® - Overweight and Obese - Adults - Phase III 17/04/2018 CATALYSIS
Oncoxin-Viusid-Advanced or metastatic ovarian epithelial cancer-Adult women-Phase II 17/04/2018 CATALYSIS
Glizigen® and Oncoxin®-Viusid® in cervical intraepithelial lesions of adult women. Phase II 09/05/2018 CATALYSIS
Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II 10/05/2018 CATALYSIS
Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase II 05/06/2018 CATALYSIS
Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase II 01/08/2018 CATALYSIS
Effect and safety of the use of Viusid® on the quality of life of patients with Chronic Kidney Disease on Hemodialysis. 27/03/2023 CATALYSIS
Quality of life and safety of CARMINAL® nutritional supplement in patients with mild or moderate ulcerative colitis 29/02/2024 CATALYSIS
Quality of Life and safety of the nutritional supplement Deprexil® or Placebo in combination with cognitive stimulation treatment in patients with Mild Cognitive Impairment and Mild Alzheimer's Dementia. 07/03/2024 CATALYSIS
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer 24/04/2023 CBQ
Melagenina Plus - Vitiligo – phase IV 14/01/2019 CHP